Gandhi S, Torka P, Hernandez-Ilizaliturri FJ. The Emerging role of Checkpoint Inhibitors in Lymphoid Malignancies. The Journal of Targeted Therapies in Cancer. 2015; 12.15: 53-62.
Torka P, Al Ustwani O, Wetzler M, Wang ES, Griffiths EA. Swallowing a Bitter Pill-Oral Arsenic Trioxide for Acute Promyelocytic Leukemia. Blood Reviews. 2015 Dec 3. doi: 10.1016/j.blre.2015.11.004. [Epub ahead of print] (PMID: 26709030)
Torka P, Hahn T, Bertolo J, Liu H, Ross M, Paplham P, Jankowski A, Deeb G, Chen G, McCarthy P. Autologous Reconstitution Leading to Sustained JAK2-V617F Negativity Post Allogeneic Hematopoietic Stem Cell Transplant in JAK2-V617F Positive Myelofibrosis. Bone Marrow Transplant. 2015 Nov;50(11):1480-2. doi: 10.1038/bmt.2015.169. Epub 2015 Jul 27. (PMID: 26214139)
Torka P, Griffiths E. Engineered T-cells for leukemia: a Review of Current Approaches and Applications. The Journal of Targeted Therapies in Cancer. 2015; 6.15:56-65.
Torka P, Gill S. Cotton Fever: An Evanescent Process Mimicking Sepsis in an Intravenous Drug Abuser. J Emerg Med. 2013 Jun;44(6):e385-7
Torka P, Aggarwal A. A 55-year old man with pruritic skin nodules. Neth J Med. 2012 Dec;70(10):466, 471.
Din N, Torka P, Hutchison RE, Riddell S, Wright J, Gajra A. Severe Isospora (Cystoisospora) belli diarrhea preceding the diagnosis of Human T-cell Leukemia Virus-1 associated T-cell Lymphoma. Case Rep Infect Dis. 2012;2012:640104.
Torka P, Sharma R. Green Urine. Neth J Med. 2012 Aug;70(6):282, 285
Torka P, Sharma R. Cannabinoid and Hyperemesis. Mayo Clin Proc. 2012; 87(5): 502-503
Sharma R, Torka P. Painless lumps: A manifestation of granulocytic sarcoma. Am J Med. 2010; 123 (10): 902-903
Torka P, Sharma R, Sood R. Rodenticide poisoning as a cause of quadriparesis: a rare entity. Am J Emerg Med. 2009; 27(5): 625. e1-3
Expert Group of the Association of Physicians of India on Adult Immunization in India. Executive Summary, The Association of Physicians of India Evidence-Based Clinical Practice Guidelines on Adult Immunization. J Assoc Physicians India. 2008; 57: 345-356
Pal GK, Pal P, Nanda N, Torka P. Effects of cholinomimetics injected into nucleus accumbens on food and water intake in rats. Biomedicine. 2008; 28: 43-46.
Sharma R, Torka P. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology. 2008; 48(6): 2085-86.
Torka P. ‘Healing toes?!!’ How my attending taught me much more than just the ‘science’ of medicine. Upstate of Mind, Spring 2012 edition.
ENDO 2012, The Endocrine Society's 94th Annual Meeting & Expo. June 24th 2012, Houston, TX Dhaliwal R, Torka P (presenting author), John D, Kelly J, Moses A. Milk-Alkali Syndrome: A Re-Surfacing Cause of Hypercalcemia.
National ACP Conference, April 19th 2012, New Orleans, LA. Torka P, Buchan D. Flatbush Diabetes: Freedom from needles.
New York State Thoracic Society Annual Scientific Assembly, 2012, New York, NY. Torka P, Bair A. Lung cancer masquerading as atrial thrombus: a ticking time bomb.
Canadian Refugee Conference, 2011, Toronto, Canada. Torka P, Cronkright P, Arif O, Malhotra A. Managing Hepatitis B: A process- Improvement in Primary Care.
CHEST 2010. The annual meeting of American College of Chest Physicians, Vancouver, Canada. Torka P, Sharma SK, Guleria R, Sood S, Broor S, Kapil A, Khilnani GC. (2010). Microbial Patterns in Severe Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation- Results from a tertiary care center in India.
British Society of Rheumatology Annual Meeting, 2008, Liverpool, United Kingdom. Torka P, Aneja R, Thabah MM, Vaidya B, Gupta R, Kumar A, Yadav RK, Deepak KK. Autonomic nervous system dysfunction in Rheumatoid Arthritis.
Mehta R, Torka P, Patel P, Przepolewski A, Levine E. A Survey of Outpatient Chemotherapy Dosing Practices among Obese Patients in a Tertiary Care Cancer Center: Identification of Barriers and Implementation of Full Weight-Based Dosing. NCCN Annual Conference 2016, Hollywood FL.
Torka P, Wallace P, Zhang Y, Chen G, Ho C, Balderman S, Ross M, Paiva B, Hernandez-Ilizaliturri FJ, McCarthy PL, Hahn T. Analysis of Immune Reconstitution after Autologous Hematopoietic Cell Transplant (AHCT) in Diffuse Large B-cell Lymphoma (DLBCL) and Mantle Cell Lymphoma (MCL) Patients Mobilized with Granulocyte Colony Stimulating Factor (G-CSF), with or without Plerixafor. Biology of Blood and Marrow Transplant 2016; 22(3); S155- S156
Torka P, Patel P, Tan W, Wilding G, Bhat SA, Czuczman MS, Lee KP, Deeb G, Neppalli V, Mavis C, Hernandez Ilizaliturri FJ. Augmenting Neutrophil Function By Administration of Peg-Filgrastim Potentiates Rituximab and Is Safe in Patients with Indolent B-Cell Non-Hodgkin Lymphomas: Results of a Phase II Study. Blood 2015; 126(23):3975
Torka P, Wallace P, Zhang Y, Chen G, Balderman S, Paiva B, Ho C, Ross M, Hernandez-Ilizaliturri FJ, McCarthy PL, Hahn T. Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma. Blood 2015; 126(23):3173
Torka P, Patel P, Tan W, Wilding G, Mavis C, Deeb G, Lee KP, Bhat SA, Czuczman MS, Hernandez Ilizaliturri FJ. Peg-filgrastim potentiates rituximab in patients with indolent lymphomas:results of a phase II study. Clinical Lymphoma, Myeloma & Leukemia 2015. 15(2):S72.
Torka P, Hernandez-Ilizaliturri FJ, Bhat SA, Czuczman MS, Basra P, Kuvshinoff BW, Deeb G, Skitzki JJ, Neppalli V. Impact of clinical parameters on surgical outcomes in patients with hematological disorders undergoing splenectomy. J Clin Oncol 33, 2015 (suppl; abstr e17689)
Torka P, Hernandez Ilizaliturri FJ, Belliotti S, Mavis C, Gu J, Czuczman MS. Inhibition of the Nuclear Factor Kappa B (NFB)/Interferon Regulatory Factor 4 (IRF4) Signaling Pathway in Activated B-cell (ABC) Diffuse Large B-cell Lymphoma (DLBCL) by Combining MLN4924, a Novel NEDD8 Activating Enzyme Inhibitor (NAE) and Ibrutinib. Blood 2014; 124(21):1768
Patel P, Torka P, Neppalli V, Deeb G, Sait SNJ, Block AW, Bhat SA, Czuczman MS, Hernandez Ilizaliturri FJ. Intense cytarabine-based chemo-immunotherapy, central nervous system (CNS) prophylaxis and early high-dose chemotherapy and autologous stem cell support (HDC-ASCS) in first remission are associated with an improved clinical outcome in double-hit (DHL)/triple-hit (THL) diffuse large B-cell lymphoma. Blood 2014; 124(21):1768
Hardin C, Torka P, Panuganty V, Wand D, Spektor Z, Duffy S, Gajra A. Evaluation of Laboratory and Clinical Markers for Predicting Survival in TTP/HUS: A Single Center Retrospective Study. Blood 2013; 122(21):108
Aggarwal A, Aggarwal S, Kalamkar B, Torka P. YouTube as a Source of Information for Gallstone Disease. Am J Gastroenterol 2012; 107:S67–S112